mily provides one of the most powerful all natural antimicrobial agents found in nature - Lauric Acid. When applied to the skin, Northstar's patent pending formula goes to work, killing over 99.98% of the bacteria that causes acne, Propionibacterium acnes (P. acnes), in just 10 minutes or less. Northstar Biosciences has combined antimicrobial agents, together with other all-natural, plant-derived ingredients to deliver a soothing cream that minimizes the inflammation due to acne flare-ups.
Why not stick with what you know? Unlike products formulated around harsh chemical treatments - Benzoyl Peroxide and Salicylic Acid - peeling, itching, irritation, reddened skin, dryness and other long-term skin damage will not occur with clear and natural products. In fact, the effectiveness and safety of Lauric Acid has been researched and proven for over 25 years in numerous scientific studies and is deemed GRAS (generally recognized as safe) by the FDA.
clear and natural beta tester, Lindsey McQuesten , an 18 year old college student from Massachusetts said, "I used the acne cream by itself for six weeks and thought it worked really well against my existing acne. However, once I started the twice daily cleansing cream routine combined with direct acne cream applications, I noticed a huge reduction in the frequency and the severity of my acne breakouts." She continued, "This is better than any product I have ever tried – and believe me, I've tried them all."
McQuesten's mother, Deb Toland , remarked, "When Lindsey came home from college, I immediately noticed how good her skin looked. I was thrilled for her. The skin inflammation was virtually gone and her chin area, where she usually experienced her worst blemishes, was completely clear."
"Most people that suffer with acne find it a soPage: 1 2 3 Related biology technology :1
. New Applications of Pressure BioSciences PCT Platform Prominently Featured at Scientific Conference on Technologies for Protein Research2
. INVENT Ventures and Heliant Ventures Seek to Accelerate Personalized Medicine Research, Co-Invest in Sanguine BioSciences3
. INVENT Ventures and Heliant Ventures Seek to Accelerate Personalized Medicine Research with Seed Round Investment in Sanguine BioSciences4
. Ambit Biosciences Files Registration Statement for Proposed Initial Public Offering5
. Nano3D Biosciences Releases 96-well BioAssembler for 3D Cell Culture6
. Neurocrine Biosciences Reports Fourth Quarter And Year End 2012 Results7
. Sangamo BioSciences Announces Fourth Quarter And Full Year 2012 Conference Call And Webcast8
. IntelliCell BioSciences Announces the Addition of Harry Fisch, MD as Director of Urology9
. Avelas Biosciences Closes $7.65 Million Series A, Advances Real-Time Tumor Visualization Technology Toward Development10
. Pressure BioSciences, Inc. Appoints Conrad F. Mir as Chief Financial Officer11
. IntelliCell BioSciences Announces Research Agreement with the New Jersey Center for Biomaterials at Rutgers-The State University of New Jersey